229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
28.78%
Positive revenue growth while VUZI is negative. John Neff might see a notable competitive edge here.
28.95%
Positive gross profit growth while VUZI is negative. John Neff would see a clear operational edge over the competitor.
47.43%
EBIT growth 1.25-1.5x VUZI's 42.86%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
47.43%
Operating income growth 1.25-1.5x VUZI's 42.86%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
41.29%
Net income growth comparable to VUZI's 43.28%. Walter Schloss might see both following similar market or cost trajectories.
41.14%
EPS growth similar to VUZI's 43.48%. Walter Schloss would assume both have parallel share structures and profit trends.
41.96%
Similar diluted EPS growth to VUZI's 43.48%. Walter Schloss might see standard sector or cyclical influences on both firms.
0.23%
Share reduction more than 1.5x VUZI's 1.04%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.44%
Reduced diluted shares while VUZI is at 1.04%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-8.31%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-7.44%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
261.82%
10Y CAGR of 261.82% while VUZI is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
313.21%
5Y CAGR of 313.21% while VUZI is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
65.24%
3Y CAGR of 65.24% while VUZI is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
974.64%
OCF/share CAGR of 974.64% while VUZI is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
1366.02%
OCF/share CAGR of 1366.02% while VUZI is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
1200.18%
3Y OCF/share CAGR of 1200.18% while VUZI is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
542.57%
10Y net income/share CAGR of 542.57% while VUZI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
1977.02%
Net income/share CAGR of 1977.02% while VUZI is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
165.43%
3Y net income/share CAGR of 165.43% while VUZI is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
624.97%
Equity/share CAGR of 624.97% while VUZI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
331.35%
Equity/share CAGR of 331.35% while VUZI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
155.43%
Equity/share CAGR of 155.43% while VUZI is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-27.44%
Firm’s AR is declining while VUZI shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-22.20%
Inventory is declining while VUZI stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
18.29%
Asset growth of 18.29% while VUZI is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
2.51%
BV/share growth of 2.51% while VUZI is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
No Data
No Data available this quarter, please select a different quarter.
5.70%
We increase R&D while VUZI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
9.21%
We expand SG&A while VUZI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.
